History of ANA testing The LE cells In vitro damaged white cells are coated with “LE Factor” LE factor: a family of antibodies to nuclear constituents.

Slides:



Advertisements
Similar presentations
Lupus in children and teens
Advertisements

Lupus in Pregnancy Darren Farley, MD Clinical Assistant Professor
Overview of Rheumatology Labs: Alphabet soup?
(SLE).  Definition  Epidemiology  Pathophysiology  Clinical features  Classification and diagnosis  Treatment  Prognosis  Lupus related syndromes.
Sytemic Lupus Erythematosis The New Understanding: Complexity and Promise Jan L Hillson MD.
1 IN THE NAME OF GOD. 2 SYSTEMIC LUPUS ERYTHEMATOSIS (SLE)
Systemic Lupus Erythematosus and Pregnancy:An Overview
DR SANTOSH KUMAR ASSISTANT PROFESSOR MEDICINE UNTI 2.
ANA Testing Carrie Marshall 1/18/08.
William E Davis, MD, FACP.  Markers of inflammation ◦ ESR ◦ CRP  Rheumatoid factor and anti-CCP antibodies  Anti-nuclear antibodies.
Anti-nuclear antibodies
Autoantibodies in PM and DM Autoantibodies:>90% Autoantibodies:>90% Positive ANA:60-80% Positive ANA:60-80%  More in overlap  Low in IBM Defined antibodies:50%
Introduction to the design of diagnostic criteria Joop P van de Merwe Dept. of Immunology & Internal Medicine Erasmus MC Rotterdam
Autoimmune Diseases Dr. Raid Jastania. Autoimmune Diseases Group of diseases with common pathological process Presence of auto-antibody ?defect in B-cells.
Value of inflammatory markers Useful for diagnosis of inflammatory vs non inflammatory conditions Remember NON-SPECIFIC, increased in infection, inflammation,
Gender Differences in Immune Response Females resist a variety of infections better than males ??? Females may reject transplanted organs more rapidly.
Systemic Lupus Erythematosus
Lupus: Symptoms, Diagnosis and Treatment
DIAGNOSIS of AUTOIMMUNE DISEASES Assos. Prof. Gülderen Yanıkkaya Demirel MD, PhD Yeditepe University School of Medicine Immunology Department, Medical.
Rheumatology Labs: Alphabet soup? Pediatric Rheumatology Red Team Resident Teaching Series.
Dr Shoaib Raza.   Immune reactions against self antigens  Affects 1% to 2% of US population  Requirements for an autoimmune disorder:  Presence of.
Brenda Beckett, PA-C Clinical Assessment II
SLE Systemic Lupus Erythematous
Clinical Immunology Conleth Feighery John Jackson.
Anti-Nuclear Antibody Tests
No history of arthritis Significant cardiomegaly on chest x-ray
Interventions for Clients with Connective Tissue Disease and Other Types of Arthritis.
Paediatric Rheumatology Phil Riley Consultant Paediatric Rheumatologist Teaching.
SLE SUBSETS Discoid lupus erythematosus (DLE)
Laboratory Tests in Rheumatology
Endocrinology Thyroid Function Tests Case F Tu Nguyen Tuan Tran Thi Trang.
AUTOANTIBODIES IN RHEUMATOLOGY G. Cooke VTS Trainee.
DIAGNOSTIC AUTOANTIBODIES
Disorders associated with a positive test for Rheumatoid Factor
Testing in the Rheumatic Diseases Salahuddin Kazi, M.D.
Good Morning ! October 3 rd,  An overlap syndrome associated with anti-U1-RNP (ribonucleic protein) antibodies with features of SLE, scleroderma,
ANTI-Ro/SSA 52 ANTIBODIES IN AUTOIMMUNE DISEASES Coordinator: Monica Copotoiu MD,PhD First author: Gabriela Mihai Coauthors: Isabela Micu, Mihaela Budianu,
Inflammatory Illnesses. Aims Appreciate the impact of inflammatory illnesses on patients’ lives Know how to identify and manage common inflammatory disorders.
Interventions for Clients with Connective Tissue Disease and Other Types of Arthritis.
Rheumatology Review. How to Approach Arthritis DURATION ACUTECHRONIC INFLAMMATION? YESNO Crystal Deposition Infection Early Chronic Trauma Hemarthrosis.
Elsevier items and derived items © 2006 by Elsevier Inc. Interventions for Clients with Connective Tissue Disease and Other Types of Arthritis.
Rheumatology Panel for Primary Care
Mixed Connective Tissue Disease
Autoantibodies in LE R3 Anchisa Srivipatana. Antinuclear antibody (ANA)
RHEUMATOID ARTHRITIS (RA)
From ANA to ENA: daily practice in the Netherlands
Clinical Immunology Overview and use of the Laboratory.
RHEUMATOID ARTHRITIS (RA). Introduction RA is a chronic, systemic inflammatory disorder of unknown etiology characterized by the manner in which it involved.
Autoantibodies associated with Rheumatic disease
RHEUMATOLOGY TESTING Maureen Sestito, D.O. PCOM Internal Medicine Residency.
3e Initiative 2009 How to investigate and follow-up Undifferentiated Peripheral Inflammatory Arthritis? Case 2.
ANA Testing Carrie Marshall 1/18/08 1.
Scleroderma Raynaud’s phenomenon Iraj Salehi-Abari MD., Internist
Publication No
Dr. Ashwin Kulkarni M.S.Ramaiah Medicial College Bangalore India
Dr.Babur Salim Student in Rheumatology deptt. FFH
Tests for Rheumatoid Arthritis
“Mixed Connective Tissue Disease: Still Crazy After All These Years”
Systemic Lupus Erythematosis
3. AUTOIMMUNITY Immune Mechanisms Tolerance 4. Rheumatologic diseases
Systemic Lupus Erythematosus
Dr Chandrashekara S Medical Director
Autoimmune diseases Ali Al Khader, M.D. Faculty of Medicine
Figure 1 Historical evolution of the clinical classification and
SIBM: Epidemiology. sIBM: Epidemiology Disease Characteristics: Distinctive Patterns of Muscle Involvement.
Nephrology cases Dr . Hayam Hebah.
Autoimmune diseases Ali Al Khader, M.D. Faculty of Medicine
Hashimoto’s Encephalitis
common rheumatologic diagnoses
Presentation transcript:

History of ANA testing The LE cells In vitro damaged white cells are coated with “LE Factor” LE factor: a family of antibodies to nuclear constituents Late 1950’s: many in vitro immuno-fluorscence based tests developed Titers (>&=1:40 increase in specificity;patterns of immunostaining: change of substrate (Hep-2) brings >increase in sensitivity, now pos if >1:80) Change of substrate (HEp-2) Low sensitivity for anti-Ro/SSA antibodies EIA/ELISA testing=lower cost of testing, easier to perform Specific auto Abs to nuclear Ags (SSA,SSB, ds-jilDNA) Point 2

HISTORY OF ANA TESTING

When should an ANA test be ordered? When there is a clinical evaluation that has led to a presumptive diagnosis

CONDITIONS ASSOCIATED WITH POSITIVE ANA TEST Very useful –Scleroderma (60-90%),SLE (95-100%) Somewhat useful –Sjogren’s syndrome (40-70%) idiopathic inflammatory myositis (dermato/polymyositis) (30-80%)

CONDITIONS ASSOCIATED WITH+ ANA Diseases for which ANA is useful for monitoring /prognosis –Juvenile chronic oligoarticular arthritis with uveitis –Raynaud’s phenomenon Diseases for which a positive ANA test is an intrinsic part of diagnostic criteria –Drug-induced SLE –MCTD

Titer significance > 1: 40 = NEGATIVE > 1: 80 – 1: 160 = low titer positive > 1: 160 = positive, more likely to have autoimmune disease

Diseases for which an ANA test is NOT useful in diagnosis Rheumatoid arthritis 30-50% Multiple sclerosis 10-30% Thyroid disease 30-50% Discoid lupus 5-25% Infectious diseases wide variations Malignancies wide variations Patients with silicone breast implants 15-25% Fibromyalgia 15-25% Healthy relatives of pts with SLE or Scleroderma 5-25%

Conditions with +ANA Autoimmune disease Infectious disease Medications Epidemiology Conditions Very High Titers: more likely to have autoimmune disease, but does NOT indicate disease activity

ANA Patterns Homogenous chromatin (but homogenous histone is drug related) Rim pattern (chromatin 1013& nuclear membrane) Fine speckled (nuclear RNP & chromatin..but more common in other CTD)

ANA PATTERNS & ASSOCIATIONS Homogenous Pattern-also present in % of SLE Anti-Histone: Drug SLE

Nuclear RNP Specific for MCTD (100)% of pts with MCTD) Also present in 30-40% of SLE Assoc with MCTD, overlap SLE, and also DM/PM, and Scleroderma

Speckled CREST syndrome (CREST has speckles in the center) Anti-Centromere present in 70-85% of pts with limited scleroderma/CREST Anti-centromere present in <5% of SLE Associated with Raynaud’s phenomena

CYTOPLASMIC/ANTI RIBOSOMAL Psychiatric Lupus

AUTOANTIBODY ASSOCIATIONS ANA is sensitive Anti-Sm and DS-DNA are specific ANA in a primary care setting: Sensitivity=100%,Specificity=67% Negative ANA is useful, however +ANA present in many DX and in normals(5- 40%)

Autoantibody specificity: Specific for SLE Anti SM ( RNP) Present in 30-40% of SLE Very uncommon in other diseases Associated with Interstitial Lung Disease Specificity: Sjogen’s (60-70% of pts with Sjogren’s)

Ro(SSA) and La (SSB). Ro present in 25-30% of SLE, La also present in 10-15% of SLE Also associated with subacute cutaneous lupus Anti-Ro (NOT La): Neonatal lupus with heart block (babies drown from Ro boats)

ANTI-JO-1 Specificity: present in 40-50% of pts with Polymyositis/Dermatomyositis, especially with pulmonary interstitial disease & arthritis Present in < 5% of SLE

SCL-70 (topoismerase 1) PSS (Progressive Systemic Sclerosis) (40-70% of pts with Diffuse PSS)

When should an ANA test be ordered? When there is a clinical evaluation that has led to a presumptive diagnosis

ANA :FAQs What tests should be performed in young women with symmetric arthralgias? A) arthralgias (not arthritis), 6weeks- NOTHING,CMV,HSV,VZV VIRUSES frequently-HBV,HAV, HCV< rubella(vaccine as well), parvo, occasionally, EBV,HIV,mumps,coxsackie,echo,adeno,CMV HSV, VZV

ANA: FAQs B) arthralgias > 6 weeks or Arthritis- Further investigation

ANA : FAQs What other testing should be done after a + ANA in an asymptomatic patient? NOTHING more……Consider following for 3-5 years? What tests should be done in young women with symmetric arthralgias? A) arthralgias (not arthritis) < 6 wks- NOTHING Viruses frequently, HBV, HCV,rubella (vaccine), parvo, occasionally-EBV,HIV, mumps,

RAMIFICATIONS OF + ANA Patients spend the rest of their lives waiting to get sick, still think they are sick, request disability in the absence of any rheumatological disease findings, one person telling them a +ANA implies Lupus seems to outweigh several people telling them there is nothing wrong with them, all symptoms they have the rest of their lives are due “to my Lupus”, which they don’t have